Pediatric Cardiomyopathy Genetic Study
This study aims to understand the genetic causes of cardiomyopathy (a disease of the heart muscle) in children. Researchers will collect information from children with cardiomyopathy and their family members to identify the specific genes involved. The goal is to improve genetic counseling, understand how the heart works normally and abnormally, and develop better ways to manage and treat pediatric cardiomyopathy. There are no specific drugs or interventions being tested in this study. The main goal is to identify the genetic causes of cardiomyopathy, which will be measured over seven years. You can join if you have cardiomyopathy or are a family member of someone with cardiomyopathy. The current recruitment status is unclear.
- Study design
- This is an observational study, meaning researchers will gather information without giving any specific treatments. It plans to include up to 300 participants.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The study aims to understand the molecular genetics of cardiomyopathy, with results measured at 7 years.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Pediatric Cardiomyopathy Mutation Analysis
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Stephanie Ware, MD, PhD · PRINCIPAL_INVESTIGATOR · IU School of Medicine
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Elucidate the molecular genetics of cardiomyopathy7 years